Myocardial Homing of Nonmobilized Peripheral‐Blood CD34+ Cells After Intracoronary Injection

Granulocyte– colony‐stimulating factor administered for autologous hematopoietic stem cell isolation from blood may favor restenosis in patients implanted after acute myocardial infarction (AMI). We therefore tested the isolation of peripheral‐blood CD34+ cells without mobilization in six patients with AMI. After large‐volume cytapheresis and positive CD34+ cell selection, 3.6 to 27.6 million CD34+ cells were obtained. We performed intra‐coronary implantation of these cells and recorded no restenosis or arrhythmia. We used positron emission tomography (PET) to assess myocardial‐labeled CD34+ cell homing, which accounted for 5.5% of injected cells 1 hour after implantation. In conclusion, large amounts of CD34+ cells, in the range reported in previous studies, can be obtained from nonmobilized peripheral blood. PET with [18F]‐fluorodeoxyglucose cell labeling is an efficient imaging method for homing assessment.

[1]  I. Komuro,et al.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.

[2]  P. Tiberghien,et al.  Can stem cells mend a broken heart? , 2005, Cardiovascular research.

[3]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[4]  S. Ogawa,et al.  Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[5]  S. Kitamura,et al.  G-CSF Promotes Bone Marrow Cells to Migrate into Infarcted Mice Heart, and Differentiate into Cardiomyocytes , 2004, Cell transplantation.

[6]  I. Komuro,et al.  Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[8]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[9]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[10]  P. Merlet,et al.  Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. , 2003, Blood.

[11]  A. Becker,et al.  T lymphocytes in atherogenesis-functional aspects and antigenic repertoire. , 2003, Cardiovascular research.

[12]  Z. Estrov,et al.  Adult stem cells for tissue repair - a new therapeutic concept? , 2003, The New England journal of medicine.

[13]  Pascal J. Goldschmidt-Clermont,et al.  Aging, Progenitor Cell Exhaustion, and Atherosclerosis , 2003, Circulation.

[14]  S. Kitamura,et al.  G-CSF Promoted Bone Marrow Cells to Migrate into Infarcted Heart and Differentiate into Cardiomyocytes , 2003 .

[15]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[16]  Harvey Feigenbaum,et al.  Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  A. Deten,et al.  Hematopoietic stem cells do not repair the infarcted mouse heart. , 2005, Cardiovascular research.